# Phase 1 Colitis, Ulcerative trials recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 1 for Colitis, Ulcerative that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 Colitis, Ulcerative trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/colitis-ulcerative

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07932691 | Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative Colitis | Beijing VDJBio Co., LTD. | Phase 1 | Recruiting | Ulcerative Colitis (UC) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932691) |
| November 6, 2026 | NCT07923383 | An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates | Sanofi | Phase 1 | Not yet recruiting | Ulcerative Colitis, Crohn's Disease | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923383) |
| October 28, 2026 | NCT07900945 | Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants | Keymed Biosciences Co.Ltd | Phase 1 | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900945) |
| October 9, 2026 | NCT07869225 | A Phase I, Randomized, Double-Blind, Placebo-Controlled Study of EQ504 in Single and Multiple Ascending Doses in Healthy Volunteers | Equillium | Phase 1 | Not yet recruiting | Ulcerative Colitis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869225) |
| September 22, 2026 | NCT07834515 | Phase 1b Clinical Study in Patients With Active Ulcerative Colitis | Thetis Pharmaceuticals LLC | Phase 1 | Not yet recruiting | Ulcerative Colitis (UC) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834515) |
| September 15, 2026 | NCT07819799 | Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis | Attovia Therapeutics Inc | Phase 1 | Not yet recruiting | Ulcerative Colitis (UC) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819799) |
| August 17, 2026 | NCT07768254 | A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative... | Helixon Biotechnology (Suzhou) Co., Ltd | Phase 1 | Not yet recruiting | Colitis, Ulcerative | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768254) |
| August 6, 2026 | NCT07749768 | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and... | Ono Pharmaceutical Co., Ltd. | Phase 1 | Recruiting | Ulcerative Colitis (UC) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749768) |
| August 5, 2026 | NCT07747480 | A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis | GlaxoSmithKline | Phase 1 | Recruiting | Colitis, Ulcerative | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747480) |
| August 5, 2026 | NCT07747467 | A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative... | GlaxoSmithKline | Phase 1 | Recruiting | Colitis, Ulcerative | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747467) |
| August 4, 2026 | NCT07744646 | Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis | The First Affiliated Hospital of Anhui Medical University | Phase 1 | Not yet recruiting | Ulcerative Colitis (UC) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07744646) |
| June 8, 2026 | NCT07632573 | A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult | Benethera (Shaoxing) Biotechnology Co., Ltd. | Phase 1 | Recruiting | Ulcerative Colitis (UC), Ulcerative Colitis (Disorder), Ulcerative Colitis Acute, IBD (Inflammatory Bowel Disease), CD... | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632573) |
| February 18, 2026 | NCT07416383 | Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 1 | Not yet recruiting | Inflamatory Bowel Disease, Crohn Disease (CD), Ulcerative Colitis (UC) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07416383) |
| February 10, 2026 | NCT07401680 | Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population | University of Alberta | Phase 1 | Recruiting | Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401680) |
| December 27, 2024 | NCT06749795 | LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC) | Liveome Inc. | Phase 1 | Not yet recruiting | Ulcerative Colitis (UC) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06749795) |
| December 4, 2024 | NCT06715540 | Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects | Biocad | Phase 1 | Recruiting | Healthy | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06715540) |
| May 10, 2023 | NCT05852587 | Xylitol Use for Decolonization of C. Difficile in Patients With IBD | Brigham and Women's Hospital | Phase 1 | Not yet recruiting | Inflammatory Bowel Diseases, Clostridioides Difficile Infection | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05852587) |
| December 28, 2022 | NCT05666960 | R-3750 in Patients With Mild to Moderate Ulcerative Colitis | Rise Therapeutics LLC | Phase 1 | Recruiting | Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic, Ulcerative Colitis | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05666960) |
| December 21, 2022 | NCT05659953 | LMT503 First-in-human SAD, MAD, and FE Study | Lmito Therapeutics Inc. | Phase 1 | Not yet recruiting | Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn Disease | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05659953) |
| January 25, 2019 | NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | National Cancer Institute (NCI) | Phase 1 | Recruiting | Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm, Inflammatory Bowel... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03816345) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 2 |
| The First Affiliated Hospital of Anhui Medical University | 1 |
| Rise Therapeutics LLC | 1 |
| Helixon Biotechnology (Suzhou) Co., Ltd | 1 |
| [Ono Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/ono-pharmaceutical-co-ltd) | 1 |
| Beijing VDJBio Co., LTD. | 1 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| National Cancer Institute (NCI) | 1 |
| Brigham and Women's Hospital | 1 |
| [Biocad](https://specstream.ai/data/clinical-trials/company/biocad) | 1 |
| [Keymed Biosciences Co.Ltd](https://specstream.ai/data/clinical-trials/company/keymed-biosciences-co-ltd) | 1 |
| Thetis Pharmaceuticals LLC | 1 |
| Benethera (Shaoxing) Biotechnology Co., Ltd. | 1 |
| University of Alberta | 1 |
| Equillium | 1 |
| Liveome Inc. | 1 |
| Lmito Therapeutics Inc. | 1 |
| Attovia Therapeutics Inc | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 5 |
| United States | 4 |
| United Kingdom | 2 |
| Canada | 2 |
| Russia | 1 |
| Australia | 1 |
| Poland | 1 |
| Netherlands | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B energy and utility companies in the United States](https://specstream.ai/data/businesses/b2b-energy-and-utility-companies/united-states)
- [Dialysis clinics in the United States](https://specstream.ai/data/businesses/dialysis-clinics/united-states)
- [Hydro jetting companies in the United States](https://specstream.ai/data/businesses/hydro-jetting-companies/united-states)
- [Pediatric gastroenterology practices in the United States](https://specstream.ai/data/businesses/pediatric-gastroenterology-practices/united-states)
- [Textile manufacturers in the United States](https://specstream.ai/data/businesses/textile-manufacturers/united-states)
- [Backflow companies in the United States](https://specstream.ai/data/businesses/backflow-companies/united-states)
